As difficult as it is for adults to deal with Migraine disease and headache disorders, it's always worse to see our children suffer with them.
Children may begin getting Migraines and/or headaches at a very young age, some before they're old enough to... Read more
May 20, 2009, is a very significant date in my life. It was the day I had my Social Security Disability (SSDI) hearing. The day it was confirmed I am "fully disabled," the day it was verified I am not an able-bodied person, the day I "won" my case due to chronic pain from my fall 12 years ago.
I guess I should be relieved, happy, or even... Read more
Are you interested in clinical trials of new Migraine medications?
Clinical trials of medications and other treatments for Migraines, headaches, and other conditions are conducted for a variety of reasons. They gather data to determine if medications and other treatments are effective, if they're safe, what potential side effects they may... Read more
The FDA has approved a new prescription medication for the acute treatment of Migraine attacks, Cambia, developed by Kowa Pharmaceuticals America (KPA). Cambia is a combination of diclofenac (brand name Voltaren), a non-steroidal anti-inflammatory drug (NSAID) and potassium bicarbonate. In clinical trials, Cambia was shown to be effective for... Read more
Almotriptan, better known as Axert and Almogran, is one of eight triptan medications developed to abort a Migraine attack in adults. Until now, there has not been an FDA approved Migraine abortive treatment for adolescents under the age of 18.
This week there was exciting news: the FDA approved Axert for... Read more